Biochip Market Analysis 2018-2027: Bio-Rad Laboratories, Abbott, Illumina, Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, Fluidigm Corporation and Cepheid

The Biochip Market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The global biochip market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

Get sample PDF copy: http://bit.ly/2WjnySo

The biochip market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing development of targeted and personalized medicines for cancer treatment, growing applications in the field of proteomics, genomics, gene sequencing, drug discovery and many more. However, the increasing applications for biochips is anticipated to offer growth opportunities for the players operating in the biochip market.

Leading Industry Players:

1. Thermo Fisher Scientific Inc
2. Bio-Rad Laboratories, Inc.
3. Abbott
4. Illumina, Inc.
5. GENERAL ELECTRIC
6. Agilent Technologies, Inc.
7. PerkinElmer Inc.
8. F. Hoffmann-La Roche Ltd
9. Fluidigm Corporation
10. Cepheid

North America accounted for the largest market share of biochip market, owing to the factors such as, increasing R&D activities and rising prevalence of cancer in the region. However, Asia-Pacific region is expected fastest growth during the forecast period owing to rising geriatric population in the region.

The global biochip market is segmented on the basis of type, fabrication technology, application, and end-user. The biochip market is segmented into DNA chips, protein chips, Lab-On-A-Chip and other array. The other arrays segment is further bifurcated into tissue arrays and cell arrays. Based on the end user, the biochip market is segmented into hospitals & diagnostics centers, academic & research institutes, biotechnology & pharmaceutical companies.

Inquire for Discount: http://bit.ly/2WlDFyX

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global biochip market based on type and end-user. It also provides market size and forecast till 2027 for overall biochip market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

This release was published on openPR.